Current issues in the management of chronic obstructive pulmonary diseases

Respirology

Volumn 2, Issue 3, 1997, Pages 215-229

  Roche, N ^a   Huchon, Gérald J ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Chronic obstructive pulmonary disease; Management

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; METHYLXANTHINE DERIVATIVE; PLACEBO; PREDNISOLONE; SALBUTAMOL; VACCINE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DYSPNEA; EXERCISE; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG BULLA; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; NUTRITION; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SMOKING CESSATION;

EID: 0030725076     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.1997.tb00082.x     Document Type: Conference Paper

References (11)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1995; 152: S77-120.
2. Siafakas NM, Vermeire P, Pride NB et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Ear. Respir. J. 1995; 8: 1398-420.
3. Canadian Thoracic Society Workshop Group. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can. Med. Assoc. J. 1992; 147: 420-8.
4. Société de Pneumologie de Langue Française. Recommandations pour la prise en charge des bronchopneumopathies chroniques obstructives. Rev. Mal. Respir. 1997; 14: 2S1-2S91.
5. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Ann. Intern. Med. 1980; 93: 391-8.
6. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-6.
7. Viramontes JL, O'Brien B. Relationship between symptoms and health-related quality of life in chronic lung disease. J. Gen. Intern. Med. 1994; 9: 46-8.
8. Van Schayck CP, Rutten van Mölken MPMH, Van Doorslaer EKA, Folgering H, Van Weel C. Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life. Chest 1992; 102: 1384-91.
9. Eakin EG, Kaplan RM, Ries AL. Measurement of dyspnoea in chronic obstructive pulmonary disease. Qual Life Res. 1993; 2: 181-91.
10. Mahler DA, Mackowiak JI. Evaluation of the shortform 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995; 107: 1585-9.
11. Préfaut C, Donner CF. Dyspnoea and exercise training in patients with heart and lung disease. Eur. Respir. Rev. 1995; 5: 1-71.